Serena Gerhardt
Senior Clinical Research Associate at 89bio | South San Francisco, California, United States
Serena Gerhardt’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Senior Clinical Research Associate at 89bio in June 2025 - Present
Clinical Research Associate at Biomea Fusion in June 2022 - January 2025
Senior Clinical Trial Associate at Iovance Biotherapeutics, Inc. in December 2019 - June 2022
Clinical Coordinator- Early Clinical Development at Myovant Sciences in January 2019 - December 2019
Clinical Research Associate at Cpmc Research Institute in March 2017 - January 2019
Clinical Research Coordinator at Cpmc Research Institute in September 2012 - March 2017
Research Intern, Desprez and McAllister Lab at Cpmc Research Institute in January 2011 - December 2012
Remedial Tutor for Organic Chemistry at Calvin E. Bright Success Center, UC Merced in January 2011 - December 2012
Research Assistant, Barlow Lab at Barlow Lab, UC Merced in January 2010 - December 2012
Clinical Research Coordinator at Sutter Health CPMC at Pacific Coast Staffing in August 2012 - September 2012
University of California, Merced, Bachelor of Science (B.S.), August 2026
89bio was acquired by Roche in September 2025, making the company a member of the Roche Group. We look forward to advancing our innovative FGF21 analog, pegozafermin, as part of Roche’s Pharmaceuticals Division and continuing our mission to help patients with serious liver and cardiometabolic diseases. Pegozafermin is currently being evaluated in Phase 3 trials for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) and severe hypertriglyceridemia (SHTG).
Discover more about 89bio
Associate Director, Medical Affairs
Associate Director, Medical Affairs at 89bio
(January 2025 – Present)
Senior Talent Acquisition Partner | Startup & Growth-Stage Hiring | Trusted Advisor to Hiring Leaders
Recruitment Consultant at 89bio
(Jan 2024 – Present)
Talent Acquisition-Helping companies connect with fabulous talent.
Director of Talent Acquisition at 89bio
(Jan 2025 – Present)
Chief Regulatory and Quality Officer at 89bio
Chief Regulatory and Quality at 89bio
(Sep 2024 – Present)
Medical Director | Clinical Development & Medical Monitoring | Phase 1-4 Trials | Oncology | Neurology | Heptology | Metabolic | Decentralized Clinical Trials (DCTs) | KOL Engagement | Trial Enrollment Optimization
Enrollment turnaround: Increased monthly randomizations from ~20 in Q1 2025 to 55–58 by Q3 2025, achieving a 2.5× lift in accrual while reducing screen-failure rates through prescreening refinements.
ABPM sub-study leadership: Led the ambulatory blood pressure monitoring (...
Quality Systems
Associate Director, Quality Systems at 89bio
(Jan 2024 – Present)
What is Serena Gerhardt email address?
Email Serena Gerhardt at [email protected] and [email protected]. This email is the most updated Serena Gerhardt's email found in 2026.
How to contact Serena Gerhardt?
To contact Serena Gerhardt send an email to [email protected] or [email protected]. (updated on July 2026)
What company does Serena Gerhardt work for?
Serena Gerhardt works for 89bio.
What is Serena Gerhardt's role at 89bio?
Serena Gerhardt is Senior Clinical Research Associate
What industry does Serena Gerhardt work in?
Serena Gerhardt works in the Biotechnology industry.
